04.04.2016
- In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...
25.09.2015
- Siegfried Holding, the Swiss drug contract manufacturer, said it has completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the...
15.07.2015
- Germany’s antitrust authority Bundeskartellamt has approved BASF’s plans to sell its custom synthesis business, part of the Nutrition & Health division, and parts of its current...
07.05.2015
- BASF has announced that it will sell its custom synthesis business, part of its Nutrition & Health division, and parts of its current active pharmaceutical ingredients (APIs)...
02.12.2014
- Siegfried Group has acquired Hameln Pharma in Germany, consisting of Hameln Pharmaceuticals and Hameln RDS, with effect from end November 2014. Hameln Pharma is located in the city...
01.10.2014
- 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...
01.10.2014
- Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...
30.01.2014
- The Board of EFCG - the European Fine Chemicals Group - a sector group of Cefic, the European Chemicals Industry Council, has announced that it has appointed Dr Heinz Sieger as...
